Pricing Log in Create free account

Black Diamond Therapeutics, Inc. (BDTX) vs ImmuCell Corporation (ICCC)

Black Diamond Therapeutics, Inc. and ImmuCell Corporation are both Biotechnology companies. Black Diamond Therapeutics, Inc. and ImmuCell Corporation are of similar size ($92.6M and $92.5M). Black Diamond Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; ImmuCell Corporation trades at 120×. ImmuCell Corporation has the higher net margin (2.57% vs 0.00%) and the higher return on invested capital (7.84% vs 0.00%). Across the 15 metrics below, ImmuCell Corporation leads on 9 and Black Diamond Therapeutics, Inc. on 6.

Valuation

Metric BDTX ICCC Biotechnology median
P/E n/m 120.45 11.58
P/S n/m 3.01 9.61
P/B 0.96 2.94 2.26
Price to free cash flow n/m 21.83 26.41
EV/EBITDA 0.35 14.60 0.72
EV/Sales n/m 2.99 9.43
Earnings yield (46.58%) 0.83% (32.28%)
Free cash flow yield (35.52%) 4.58% (22.27%)

Profitability

Metric BDTX ICCC Biotechnology median
Gross margin 0.00% 40.32% 68.81%
Operating margin 0.00% 12.60% 0.00%
Net margin 0.00% 2.57% 0.00%
Free cash flow margin 0.00% 13.79% 0.00%
Return on equity (37.21%) 2.57% (50.30%)
Return on assets (29.21%) 1.69% (45.47%)
Return on invested capital 0.00% 7.84% 0.00%

Growth

Metric BDTX ICCC Biotechnology median
Revenue growth (TTM) — 8.49% 6.78%
EPS growth (last fiscal year) 130.71% 53.85% 29.88%
Revenue growth, 5-year CAGR — 12.50% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BDTX ICCC Biotechnology median
Debt to equity 0.00 0.26 0.00
Current ratio 7.28 4.75 4.74
Net debt to EBITDA (10.01) 1.19 1.01

Dividend

Metric BDTX ICCC Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric BDTX ICCC Biotechnology median
Market cap 92.50m 92.55m 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack